The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
Councils call for urgent changes to law that allow minibus drivers to operate without criminal record checks.
The maintenance worker spent 10 days in hospital after plunging 9.5 metres from a scaffold tower at a disused station.
Workers and managers are to stage another strike on Saturday amid a long-running dispute over jobs, pensions and closures.